Loading…

The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis

Summary Background Invasive community-onset staphylococcal disease has emerged worldwide associated with Panton-Valentine leucocidin (PVL) toxin. Whether PVL is pathogenic or an epidemiological marker is unclear. We investigate the role of PVL in disease, colonisation, and clinical outcome. Methods...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet infectious diseases 2013, Vol.13 (1), p.43-54
Main Authors: Shallcross, Laura J, Dr, Fragaszy, Ellen, MSc, Johnson, Anne M, Prof, Hayward, Andrew C, MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c731t-375595bc2dd8a20cdbf9ef4a8f91c57096e24f7ab8136663591b6c174267bb563
cites cdi_FETCH-LOGICAL-c731t-375595bc2dd8a20cdbf9ef4a8f91c57096e24f7ab8136663591b6c174267bb563
container_end_page 54
container_issue 1
container_start_page 43
container_title The Lancet infectious diseases
container_volume 13
creator Shallcross, Laura J, Dr
Fragaszy, Ellen, MSc
Johnson, Anne M, Prof
Hayward, Andrew C, MD
description Summary Background Invasive community-onset staphylococcal disease has emerged worldwide associated with Panton-Valentine leucocidin (PVL) toxin. Whether PVL is pathogenic or an epidemiological marker is unclear. We investigate the role of PVL in disease, colonisation, and clinical outcome. Methods We searched Medline and Embase for original research reporting the prevalence of PVL genes among Staphylococcus aureus pneumonia, bacteraemia, musculoskeletal infection, skin and soft-tissue infection, or colonisation published before Oct 1, 2011. We calculated odds ratios (ORs) to compare patients with PVL-positive colonisation and each infection relative to the odds of PVL-positive skin and soft-tissue infection. We did meta-analyses to estimate odds of infection or colonisation with a PVL-positive strain with fixed-effects or random-effects models, depending on the results of tests for heterogeneity. Results Of 509 articles identified by our search strategy, 76 studies from 31 countries met our inclusion criteria. PVL strains are strongly associated with skin and soft-tissue infections, but are comparatively rare in pneumonia (OR 0·37, 95% CI 0·22–0·63), musculoskeletal infections (0·44, 0·19–0·99), bacteraemias (0·10, 0·06–0·18), and colonising strains (0·07, 0·01–0·31). PVL-positive skin and soft-tissue infections are more likely to be treated surgically than are PVL-negative infections, and children with PVL-positive musculoskeletal disease might have increased morbidity. For other forms of disease we identified no evidence that PVL affects outcome. Interpretation PVL genes are consistently associated with skin and soft-tissue infections and are comparatively rare in invasive disease. This finding challenges the view that PVL mainly causes invasive disease with poor prognosis. Population-based studies are needed to define the role of PVL in mild, moderate, and severe disease and to inform control strategies. Funding None.
doi_str_mv 10.1016/S1473-3099(12)70238-4
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3530297</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1473309912702384</els_id><sourcerecordid>2844146791</sourcerecordid><originalsourceid>FETCH-LOGICAL-c731t-375595bc2dd8a20cdbf9ef4a8f91c57096e24f7ab8136663591b6c174267bb563</originalsourceid><addsrcrecordid>eNqNkl1rFDEUhgdRbK3-BCUgQr0YzedkxouKFL-goGD1NmQyZ9zUTLIm2er-ezM7a6u9UQhJSJ7z5py8p6oeEvyMYNI8_0S4ZDXDXXdM6FOJKWtrfqs6LMe85lzI27v9ghxU91K6wJhIgvnd6oAyghmR9LCK5ytAMThAYUS57D9qn4Ovv2gHPlsPyMHGBGMH61EOP8tcRsp6vdq6UC6MdmiwCXSCF0ijtE0ZJp2tQREuLfxA2g9ogqxr7bXbJpvuV3dG7RI82K9H1ec3r89P39VnH96-P311VhvJSK6ZFKITvaHD0GqKzdCPHYxct2NHjJC4a4DyUeq-JaxpGiY60jeGSE4b2feiYUfVyaK73vQTDKbUE7VT62gnHbcqaKv-vvF2pb6GS8UEw7STReB4LxDD9w2krCabDDinPYRNUoS2onghWPsfaKmJUMq6gj6-gV6ETSx_M1Os46JgMyUWysSQUoTxKm-C1dwAatcAana3xKldAyhe4h79WfRV1G_HC_BkD-hUvBuj9sama66RtCVyTuDlwkGxqBgZVTIWvIHBRjBZDcH-M5WTGwrGWW_Lo99gC-m6apWowovIrFH-albg7BfZheJa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1239451229</pqid></control><display><type>article</type><title>The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis</title><source>ScienceDirect Freedom Collection</source><creator>Shallcross, Laura J, Dr ; Fragaszy, Ellen, MSc ; Johnson, Anne M, Prof ; Hayward, Andrew C, MD</creator><creatorcontrib>Shallcross, Laura J, Dr ; Fragaszy, Ellen, MSc ; Johnson, Anne M, Prof ; Hayward, Andrew C, MD</creatorcontrib><description>Summary Background Invasive community-onset staphylococcal disease has emerged worldwide associated with Panton-Valentine leucocidin (PVL) toxin. Whether PVL is pathogenic or an epidemiological marker is unclear. We investigate the role of PVL in disease, colonisation, and clinical outcome. Methods We searched Medline and Embase for original research reporting the prevalence of PVL genes among Staphylococcus aureus pneumonia, bacteraemia, musculoskeletal infection, skin and soft-tissue infection, or colonisation published before Oct 1, 2011. We calculated odds ratios (ORs) to compare patients with PVL-positive colonisation and each infection relative to the odds of PVL-positive skin and soft-tissue infection. We did meta-analyses to estimate odds of infection or colonisation with a PVL-positive strain with fixed-effects or random-effects models, depending on the results of tests for heterogeneity. Results Of 509 articles identified by our search strategy, 76 studies from 31 countries met our inclusion criteria. PVL strains are strongly associated with skin and soft-tissue infections, but are comparatively rare in pneumonia (OR 0·37, 95% CI 0·22–0·63), musculoskeletal infections (0·44, 0·19–0·99), bacteraemias (0·10, 0·06–0·18), and colonising strains (0·07, 0·01–0·31). PVL-positive skin and soft-tissue infections are more likely to be treated surgically than are PVL-negative infections, and children with PVL-positive musculoskeletal disease might have increased morbidity. For other forms of disease we identified no evidence that PVL affects outcome. Interpretation PVL genes are consistently associated with skin and soft-tissue infections and are comparatively rare in invasive disease. This finding challenges the view that PVL mainly causes invasive disease with poor prognosis. Population-based studies are needed to define the role of PVL in mild, moderate, and severe disease and to inform control strategies. Funding None.</description><identifier>ISSN: 1473-3099</identifier><identifier>ISSN: 1474-4457</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(12)70238-4</identifier><identifier>PMID: 23103172</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Bacteremia ; Bacterial diseases ; Bacterial Toxins - genetics ; Bacterial Toxins - metabolism ; Biological and medical sciences ; Children ; Colonization ; Exotoxins - genetics ; Exotoxins - metabolism ; Heterogeneity ; Human bacterial diseases ; Humans ; Infection ; Infectious Disease ; Infectious diseases ; Leukocidins - genetics ; Leukocidins - metabolism ; Medical sciences ; Morbidity ; Pneumonia ; Population studies ; Prognosis ; Reviews ; Skin ; Soft Tissue Infections - genetics ; Soft Tissue Infections - metabolism ; Soft Tissue Infections - microbiology ; Staphylococcal Infections - genetics ; Staphylococcal Infections - metabolism ; Staphylococcal Infections - microbiology ; Staphylococcal infections, streptococcal infections, pneumococcal infections ; Staphylococcal Skin Infections - genetics ; Staphylococcal Skin Infections - metabolism ; Staphylococcal Skin Infections - microbiology ; Staphylococcus aureus ; Staphylococcus aureus - genetics ; Staphylococcus aureus - metabolism ; Tissues ; Toxins</subject><ispartof>The Lancet infectious diseases, 2013, Vol.13 (1), p.43-54</ispartof><rights>Elsevier Ltd</rights><rights>2013 Elsevier Ltd</rights><rights>2014 INIST-CNRS</rights><rights>Copyright © 2013 Elsevier Ltd. All rights reserved.</rights><rights>2013 Elsevier Ltd. All rights reserved. 2013 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c731t-375595bc2dd8a20cdbf9ef4a8f91c57096e24f7ab8136663591b6c174267bb563</citedby><cites>FETCH-LOGICAL-c731t-375595bc2dd8a20cdbf9ef4a8f91c57096e24f7ab8136663591b6c174267bb563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,4010,27904,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26728179$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23103172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shallcross, Laura J, Dr</creatorcontrib><creatorcontrib>Fragaszy, Ellen, MSc</creatorcontrib><creatorcontrib>Johnson, Anne M, Prof</creatorcontrib><creatorcontrib>Hayward, Andrew C, MD</creatorcontrib><title>The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>Summary Background Invasive community-onset staphylococcal disease has emerged worldwide associated with Panton-Valentine leucocidin (PVL) toxin. Whether PVL is pathogenic or an epidemiological marker is unclear. We investigate the role of PVL in disease, colonisation, and clinical outcome. Methods We searched Medline and Embase for original research reporting the prevalence of PVL genes among Staphylococcus aureus pneumonia, bacteraemia, musculoskeletal infection, skin and soft-tissue infection, or colonisation published before Oct 1, 2011. We calculated odds ratios (ORs) to compare patients with PVL-positive colonisation and each infection relative to the odds of PVL-positive skin and soft-tissue infection. We did meta-analyses to estimate odds of infection or colonisation with a PVL-positive strain with fixed-effects or random-effects models, depending on the results of tests for heterogeneity. Results Of 509 articles identified by our search strategy, 76 studies from 31 countries met our inclusion criteria. PVL strains are strongly associated with skin and soft-tissue infections, but are comparatively rare in pneumonia (OR 0·37, 95% CI 0·22–0·63), musculoskeletal infections (0·44, 0·19–0·99), bacteraemias (0·10, 0·06–0·18), and colonising strains (0·07, 0·01–0·31). PVL-positive skin and soft-tissue infections are more likely to be treated surgically than are PVL-negative infections, and children with PVL-positive musculoskeletal disease might have increased morbidity. For other forms of disease we identified no evidence that PVL affects outcome. Interpretation PVL genes are consistently associated with skin and soft-tissue infections and are comparatively rare in invasive disease. This finding challenges the view that PVL mainly causes invasive disease with poor prognosis. Population-based studies are needed to define the role of PVL in mild, moderate, and severe disease and to inform control strategies. Funding None.</description><subject>Bacteremia</subject><subject>Bacterial diseases</subject><subject>Bacterial Toxins - genetics</subject><subject>Bacterial Toxins - metabolism</subject><subject>Biological and medical sciences</subject><subject>Children</subject><subject>Colonization</subject><subject>Exotoxins - genetics</subject><subject>Exotoxins - metabolism</subject><subject>Heterogeneity</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infection</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Leukocidins - genetics</subject><subject>Leukocidins - metabolism</subject><subject>Medical sciences</subject><subject>Morbidity</subject><subject>Pneumonia</subject><subject>Population studies</subject><subject>Prognosis</subject><subject>Reviews</subject><subject>Skin</subject><subject>Soft Tissue Infections - genetics</subject><subject>Soft Tissue Infections - metabolism</subject><subject>Soft Tissue Infections - microbiology</subject><subject>Staphylococcal Infections - genetics</subject><subject>Staphylococcal Infections - metabolism</subject><subject>Staphylococcal Infections - microbiology</subject><subject>Staphylococcal infections, streptococcal infections, pneumococcal infections</subject><subject>Staphylococcal Skin Infections - genetics</subject><subject>Staphylococcal Skin Infections - metabolism</subject><subject>Staphylococcal Skin Infections - microbiology</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - genetics</subject><subject>Staphylococcus aureus - metabolism</subject><subject>Tissues</subject><subject>Toxins</subject><issn>1473-3099</issn><issn>1474-4457</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqNkl1rFDEUhgdRbK3-BCUgQr0YzedkxouKFL-goGD1NmQyZ9zUTLIm2er-ezM7a6u9UQhJSJ7z5py8p6oeEvyMYNI8_0S4ZDXDXXdM6FOJKWtrfqs6LMe85lzI27v9ghxU91K6wJhIgvnd6oAyghmR9LCK5ytAMThAYUS57D9qn4Ovv2gHPlsPyMHGBGMH61EOP8tcRsp6vdq6UC6MdmiwCXSCF0ijtE0ZJp2tQREuLfxA2g9ogqxr7bXbJpvuV3dG7RI82K9H1ec3r89P39VnH96-P311VhvJSK6ZFKITvaHD0GqKzdCPHYxct2NHjJC4a4DyUeq-JaxpGiY60jeGSE4b2feiYUfVyaK73vQTDKbUE7VT62gnHbcqaKv-vvF2pb6GS8UEw7STReB4LxDD9w2krCabDDinPYRNUoS2onghWPsfaKmJUMq6gj6-gV6ETSx_M1Os46JgMyUWysSQUoTxKm-C1dwAatcAana3xKldAyhe4h79WfRV1G_HC_BkD-hUvBuj9sama66RtCVyTuDlwkGxqBgZVTIWvIHBRjBZDcH-M5WTGwrGWW_Lo99gC-m6apWowovIrFH-albg7BfZheJa</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Shallcross, Laura J, Dr</creator><creator>Fragaszy, Ellen, MSc</creator><creator>Johnson, Anne M, Prof</creator><creator>Hayward, Andrew C, MD</creator><general>Elsevier Ltd</general><general>Lancet Publishing Group</general><general>Elsevier Limited</general><general>Elsevier Science, The Lancet Pub. Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2013</creationdate><title>The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis</title><author>Shallcross, Laura J, Dr ; Fragaszy, Ellen, MSc ; Johnson, Anne M, Prof ; Hayward, Andrew C, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c731t-375595bc2dd8a20cdbf9ef4a8f91c57096e24f7ab8136663591b6c174267bb563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Bacteremia</topic><topic>Bacterial diseases</topic><topic>Bacterial Toxins - genetics</topic><topic>Bacterial Toxins - metabolism</topic><topic>Biological and medical sciences</topic><topic>Children</topic><topic>Colonization</topic><topic>Exotoxins - genetics</topic><topic>Exotoxins - metabolism</topic><topic>Heterogeneity</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infection</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Leukocidins - genetics</topic><topic>Leukocidins - metabolism</topic><topic>Medical sciences</topic><topic>Morbidity</topic><topic>Pneumonia</topic><topic>Population studies</topic><topic>Prognosis</topic><topic>Reviews</topic><topic>Skin</topic><topic>Soft Tissue Infections - genetics</topic><topic>Soft Tissue Infections - metabolism</topic><topic>Soft Tissue Infections - microbiology</topic><topic>Staphylococcal Infections - genetics</topic><topic>Staphylococcal Infections - metabolism</topic><topic>Staphylococcal Infections - microbiology</topic><topic>Staphylococcal infections, streptococcal infections, pneumococcal infections</topic><topic>Staphylococcal Skin Infections - genetics</topic><topic>Staphylococcal Skin Infections - metabolism</topic><topic>Staphylococcal Skin Infections - microbiology</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - genetics</topic><topic>Staphylococcus aureus - metabolism</topic><topic>Tissues</topic><topic>Toxins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shallcross, Laura J, Dr</creatorcontrib><creatorcontrib>Fragaszy, Ellen, MSc</creatorcontrib><creatorcontrib>Johnson, Anne M, Prof</creatorcontrib><creatorcontrib>Hayward, Andrew C, MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Complete (ProQuest Database)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shallcross, Laura J, Dr</au><au>Fragaszy, Ellen, MSc</au><au>Johnson, Anne M, Prof</au><au>Hayward, Andrew C, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2013</date><risdate>2013</risdate><volume>13</volume><issue>1</issue><spage>43</spage><epage>54</epage><pages>43-54</pages><issn>1473-3099</issn><issn>1474-4457</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><abstract>Summary Background Invasive community-onset staphylococcal disease has emerged worldwide associated with Panton-Valentine leucocidin (PVL) toxin. Whether PVL is pathogenic or an epidemiological marker is unclear. We investigate the role of PVL in disease, colonisation, and clinical outcome. Methods We searched Medline and Embase for original research reporting the prevalence of PVL genes among Staphylococcus aureus pneumonia, bacteraemia, musculoskeletal infection, skin and soft-tissue infection, or colonisation published before Oct 1, 2011. We calculated odds ratios (ORs) to compare patients with PVL-positive colonisation and each infection relative to the odds of PVL-positive skin and soft-tissue infection. We did meta-analyses to estimate odds of infection or colonisation with a PVL-positive strain with fixed-effects or random-effects models, depending on the results of tests for heterogeneity. Results Of 509 articles identified by our search strategy, 76 studies from 31 countries met our inclusion criteria. PVL strains are strongly associated with skin and soft-tissue infections, but are comparatively rare in pneumonia (OR 0·37, 95% CI 0·22–0·63), musculoskeletal infections (0·44, 0·19–0·99), bacteraemias (0·10, 0·06–0·18), and colonising strains (0·07, 0·01–0·31). PVL-positive skin and soft-tissue infections are more likely to be treated surgically than are PVL-negative infections, and children with PVL-positive musculoskeletal disease might have increased morbidity. For other forms of disease we identified no evidence that PVL affects outcome. Interpretation PVL genes are consistently associated with skin and soft-tissue infections and are comparatively rare in invasive disease. This finding challenges the view that PVL mainly causes invasive disease with poor prognosis. Population-based studies are needed to define the role of PVL in mild, moderate, and severe disease and to inform control strategies. Funding None.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>23103172</pmid><doi>10.1016/S1473-3099(12)70238-4</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1473-3099
ispartof The Lancet infectious diseases, 2013, Vol.13 (1), p.43-54
issn 1473-3099
1474-4457
1474-4457
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3530297
source ScienceDirect Freedom Collection
subjects Bacteremia
Bacterial diseases
Bacterial Toxins - genetics
Bacterial Toxins - metabolism
Biological and medical sciences
Children
Colonization
Exotoxins - genetics
Exotoxins - metabolism
Heterogeneity
Human bacterial diseases
Humans
Infection
Infectious Disease
Infectious diseases
Leukocidins - genetics
Leukocidins - metabolism
Medical sciences
Morbidity
Pneumonia
Population studies
Prognosis
Reviews
Skin
Soft Tissue Infections - genetics
Soft Tissue Infections - metabolism
Soft Tissue Infections - microbiology
Staphylococcal Infections - genetics
Staphylococcal Infections - metabolism
Staphylococcal Infections - microbiology
Staphylococcal infections, streptococcal infections, pneumococcal infections
Staphylococcal Skin Infections - genetics
Staphylococcal Skin Infections - metabolism
Staphylococcal Skin Infections - microbiology
Staphylococcus aureus
Staphylococcus aureus - genetics
Staphylococcus aureus - metabolism
Tissues
Toxins
title The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T07%3A46%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20the%20Panton-Valentine%20leucocidin%20toxin%20in%20staphylococcal%20disease:%20a%20systematic%20review%20and%20meta-analysis&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Shallcross,%20Laura%20J,%20Dr&rft.date=2013&rft.volume=13&rft.issue=1&rft.spage=43&rft.epage=54&rft.pages=43-54&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(12)70238-4&rft_dat=%3Cproquest_pubme%3E2844146791%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c731t-375595bc2dd8a20cdbf9ef4a8f91c57096e24f7ab8136663591b6c174267bb563%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1239451229&rft_id=info:pmid/23103172&rfr_iscdi=true